CWM »

Protalix Biotherapeutics shares owned by CWM

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by CWM from 13F filings

Historical chart of CWM investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by CWM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by CWM

Quarter filed Position value Share count Share price at filing
2024-03-31 $0 6 0.00

More positions owned by CWM

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Microsoft Corporation (MSFT)
Apple (AAPL)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Eafe Value Etf (EFV)
Pimco Etf Tr Active Bd Etf (BOND)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Ser Tr Portfolio S&p400 (SPMD)

View all positions for CWM

Top funds holding Protalix Biotherapeutics

GSA Capital Partners
Vanguard Group
Bank of America Corporation
Bank of New York Mellon
Charles Schwab Investment Management
Barclays
Goldman Sachs Group
Citadel Advisors
Orin Green Financial
UBS Group
OZ Management
Rhumbline Advisers
Connor, Clark & Lunn Investment Management
Bailard
Commonwealth Equity Services

View all funds holding Protalix Biotherapeutics